Press Release | NeoGenomics Laboratories

October 12, 2017

NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

September 28, 2017

NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017

September 11, 2017

NeoGenomics Reports on Impacts from Hurricane Irma

July 25, 2017

NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

June 28, 2017

NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017

June 2, 2017

NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

May 15, 2017

NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

April 26, 2017

NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients